2020 Healthcare & Pharmaceutical Awards

6 GHP / 2020 Healthcare & Pharmaceutical Awards , Sep20319 Best mHealth Application 2020: Intellin® Diabetes has had an enormous impact on the health systems of countries around the world in the last few years. Effective diagnosis has made many people aware of it, but fewknowhow to handle the impact effectively. The teamat Gendius have found a way of allowing people to actively track andmonitor their condition. We take a closer look at how they’ve managed to achieve this formidable feat. Tracking and monitoring the state of someone’s diabetes is no easy feat, but that’s what the team at Gendius have managed to do. With care and attention, this innovative digital health start-up and mHealth innovator have designed Intellin®, a way of seeing how the body is working and collecting data that can be used to improve this in the long run. Intellin® came about thanks to the work of Rory Cameron and Chris Genders. Chris was an experienced sales director in the Pharmaceuticals scene as well as a diabetic. Bringing to the table an intimate knowledge not only of what it is like to have diabetes, but also how to improve the condition of others, he partnered up with Rory to bring Gendius into life. Rory brought an exceptional track record of success starting up businesses in the Pharmaceutical scene, allowing Gendius to quickly grow into one of the market leaders in mHealth. The team’s flagship product is Intellin®, designed specifically for those who have diabetes. While there are many apps available on the market, Intellin® stands apart as a way of highlighting not just the symptoms of diabetes, but the risk profile a person falls into. In this way, Intellin® works as an advisor for many, guiding them to a healthier lifestyle. The power of data has risen exponentially in many different fields over the last few years, but healthcare is an area in which this information could be utilised to make a real difference to people’s lives. The challenge has always been two-fold, firstly to collect accurate information about an individual and secondly to translate that information into an action plan that the individual can carry out. To achieve this goal, Intellin® is made of two separate systems, each intertwined for the betterment of health. Firstly, there is the app. This end is handled by the person with diabetes, gathering data and information. The other end of Intellin® is a secure dashboard for the healthcare team. Because both are designed by Gendius, it is possible for the data collected from the individual to be transformed into personalised, tailored, clinically-validated educational content. Everyone’s experience of diabetes is different, and using the latest systems is the only way of ensuring that suggestions are thoroughly bespoke. No one would consider arguing with the impressive systems that have made this process possible. Intellin® uses a proprietary smart algorithm to assess and interpret users’ comprehensive healthcare information. The collection of this data can be done in a number of ways, either through manual input, a direct link to a patient’s medical records or automatic syncing with a connected smart device. This data is then processed to highlight the most likely areas for diabetes complications, with reference to a clinical healthcare team. The app is then used to provide tailored, medically approved educational content. Finding this content, information that can be practically applied and is medically accurate, lies at the heart of the Intellin® operation. If managing this challenging condition is down to finding the right resources, the team at Gendius have opened people’s eyes to a new way of working and living their lives. Of course, Intellin® is by no means unique in its position as a diabetes app. The team have taken steps to ensure that they operate in a way that is thoroughly unique. For years, the ability to track blood glucose and blood pressure has been the key to the service these companies have provided, but the addition of clinical advice adds an element of urgency to what Intellin® offers. Instead of just being a collection of data, the data is proactively used and extrapolated. Instead of being a basic medical record, Intellin® is an app which acts as a diabetes ‘sav-nav’, helping people to plan for their futures. Having something solid to hold onto is a lifesaver for those with diabetes. It is so easy to be bombarded with a wealth of information, often out of context and with no easy way of applying it. The validation processes that are championed by Intellin® means that any information from the app is medically approved, backed up by internationally Tracking and monitoring the state of someone’s diabetes is no easy feat, but that’s what the team at Gendius have managed to do. With care and attention, this innovative digital health start-up and mHealth innovator have designed Intellin®, a way of seeing how the body is working and collecting data that can be used to improve this in the long run.